{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:23:00Z","timestamp":1785129780972,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771363"],"award-info":[{"award-number":["81771363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCQNJC81700"],"award-info":[{"award-number":["18JCQNJC81700"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10072-021-05108-2","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T06:46:29Z","timestamp":1613717189000},"page":"4249-4255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barr\u00e9 syndrome and their correlations with clinical features"],"prefix":"10.1007","volume":"42","author":[{"given":"Ming-Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-3793","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"issue":"10045","key":"5108_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barre syndrome. Lancet 388(10045):717\u2013727. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"issue":"8","key":"5108_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (2014) Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10(8):469\u2013482. https:\/\/doi.org\/10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"5108_CR3","doi-asserted-by":"publisher","first-page":"564098","DOI":"10.1155\/2015\/564098","volume":"2015","author":"Y Wang","year":"2015","unstructured":"Wang Y, Sun S, Zhu J, Cui L, Zhang HL (2015) Biomarkers of Guillain-Barre syndrome: some recent progress, more still to be explored. Mediat Inflamm 2015:564098\u2013564012. https:\/\/doi.org\/10.1155\/2015\/564098","journal-title":"Mediat Inflamm"},{"issue":"3","key":"5108_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, Brighton Collaboration GBSWG (2011) Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29(3):599\u2013612. https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.003","journal-title":"Vaccine"},{"issue":"4182","key":"5108_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.46621","volume":"187","author":"N Talal","year":"1975","unstructured":"Talal N, Grey HM, Zvaifler N, Michalski JP, Daniels TE (1975) Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis. Science 187(4182):1196\u20131198. https:\/\/doi.org\/10.1126\/science.46621","journal-title":"Science"},{"issue":"1","key":"5108_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0009-8981(76)90218-7","volume":"67","author":"J Cejka","year":"1976","unstructured":"Cejka J, Van Nieuwkoo JA, Mood DW, Kithier K, Radl J (1976) Beta2-microglobulin in human colostrum and milk: effect of breast feeding and physico-chemical characterization. Clin Chim Acta 67(1):71\u201378. https:\/\/doi.org\/10.1016\/0009-8981(76)90218-7","journal-title":"Clin Chim Acta"},{"issue":"1-2","key":"5108_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510x(77)90180-0","volume":"33","author":"JJ Starmans","year":"1977","unstructured":"Starmans JJ, Vos J, van der Helm HJ (1977) The beta 2-microglobulin content of the cerebrospinal fluid in neurological disease. J Neurol Sci 33(1-2):45\u201349. https:\/\/doi.org\/10.1016\/0022-510x(77)90180-0","journal-title":"J Neurol Sci"},{"issue":"8","key":"5108_CR8","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood-2002-09-2924","volume":"101","author":"SJ Gobin","year":"2003","unstructured":"Gobin SJ, Biesta P, Van den Elsen PJ (2003) Regulation of human beta 2-microglobulin transactivation in hematopoietic cells. Blood 101(8):3058\u20133064. https:\/\/doi.org\/10.1182\/blood-2002-09-2924","journal-title":"Blood"},{"issue":"9","key":"5108_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1136\/jnnp.50.9.1238","volume":"50","author":"JC Alvarez-Cermeno","year":"1987","unstructured":"Alvarez-Cermeno JC, Villar LM, Roy G, Ferreira A, Bootello A, Gimeno A, Gonzalez-Porque P (1987) Increased beta 2-microglobulin in CSF of multiple sclerosis. J Neurol Neurosurg Psychiatry 50(9):1238. https:\/\/doi.org\/10.1136\/jnnp.50.9.1238","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"5108_CR10","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1073\/pnas.82.12.4225","volume":"82","author":"JW Becker","year":"1985","unstructured":"Becker JW, Reeke GN Jr (1985) Three-dimensional structure of beta 2-microglobulin. Proc Natl Acad Sci U S A 82(12):4225\u20134229. https:\/\/doi.org\/10.1073\/pnas.82.12.4225","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5108_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000116674","volume":"31","author":"N Adachi","year":"1991","unstructured":"Adachi N (1991) Beta-2-microglobulin levels in the cerebrospinal fluid: their value as a disease marker. A review of the recent literature. Eur Neurol 31(4):181\u2013185. https:\/\/doi.org\/10.1159\/000116674","journal-title":"Eur Neurol"},{"issue":"3","key":"5108_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00916410","volume":"6","author":"R Hallgren","year":"1982","unstructured":"Hallgren R, Terent A, Venge P (1982) Lactoferrin, lysozyme, and beta 2-microglobulin levels in cerebrospinal fluid: differential indices of CNS inflammation. Inflammation 6(3):291\u2013304. https:\/\/doi.org\/10.1007\/BF00916410","journal-title":"Inflammation"},{"issue":"6","key":"5108_CR13","first-page":"351","volume":"18","author":"N Adachi","year":"1978","unstructured":"Adachi N, Tshukagoshi H, Murakami F, Kanai M (1978) beta2-Microglobulin levels in cerebrospinal fluid--the levels in various neurological diseases and their comparison with those in serum (author's transl). Rinsho Shinkeigaku 18(6):351\u2013357","journal-title":"Rinsho Shinkeigaku"},{"issue":"5","key":"5108_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998) Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 44(5):780\u2013788. https:\/\/doi.org\/10.1002\/ana.410440512","journal-title":"Ann Neurol"},{"issue":"3","key":"5108_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00313180","volume":"223","author":"H Lofberg","year":"1980","unstructured":"Lofberg H, Grubb AO, Sveger T, Olsson JE (1980) The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders. J Neurol 223(3):159\u2013170. https:\/\/doi.org\/10.1007\/BF00313180","journal-title":"J Neurol"},{"issue":"3","key":"5108_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000086295","volume":"14","author":"B Kepplinger","year":"2005","unstructured":"Kepplinger B, Baran H, Kainz A, Ferraz-Leite H, Newcombe J, Kalina P (2005) Age-related increase of kynurenic acid in human cerebrospinal fluid - IgG and beta2-microglobulin changes. Neurosignals 14(3):126\u2013135. https:\/\/doi.org\/10.1159\/000086295","journal-title":"Neurosignals"},{"key":"5108_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.07.001","volume":"323","author":"A Haarmann","year":"2018","unstructured":"Haarmann A, Hahnel L, Schuhmann MK, Buttmann M (2018) Age-adjusted CSF beta2-microglobulin and lactate are increased and ACE is decreased in patients with multiple sclerosis, but only lactate correlates with clinical disease duration and severity. J Neuroimmunol 323:19\u201327. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.07.001","journal-title":"J Neuroimmunol"},{"issue":"10","key":"5108_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.5966\/sctm.2015-0049","volume":"4","author":"D Wang","year":"2015","unstructured":"Wang D, Quan Y, Yan Q, Morales JE, Wetsel RA (2015) Targeted disruption of the beta2-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Transl Med 4(10):1234\u20131245. https:\/\/doi.org\/10.5966\/sctm.2015-0049","journal-title":"Stem Cells Transl Med"},{"key":"5108_CR19","doi-asserted-by":"publisher","first-page":"495402","DOI":"10.1155\/2014\/495402","volume":"2014","author":"J Svatonova","year":"2014","unstructured":"Svatonova J, Borecka K, Adam P, Lanska V (2014) Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study. Dis Markers 2014:495402\u2013495406. https:\/\/doi.org\/10.1155\/2014\/495402","journal-title":"Dis Markers"},{"issue":"2","key":"5108_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00702-014-1244-9","volume":"122","author":"Z Matejcikova","year":"2015","unstructured":"Matejcikova Z, Mares J, Prikrylova Vranova H, Klosova J, Sladkova V, Dolakova J, Zapletalova J, Kanovsky P (2015) Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study. J Neural Transm (Vienna) 122(2):273\u2013277. https:\/\/doi.org\/10.1007\/s00702-014-1244-9","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"5108_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1600-0404.1989.tb03934.x","volume":"80","author":"O Us","year":"1989","unstructured":"Us O, Lolli F, Baig S, Link H (1989) Intrathecal synthesis of beta-2-microglobulin in multiple sclerosis and aseptic meningo-encephalitis. Acta Neurol Scand 80(6):598\u2013602. https:\/\/doi.org\/10.1111\/j.1600-0404.1989.tb03934.x","journal-title":"Acta Neurol Scand"},{"key":"5108_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.aanat.2016.01.004","volume":"205","author":"M Joukal","year":"2016","unstructured":"Joukal M, Klusakova I, Dubovy P (2016) Direct communication of the spinal subarachnoid space with the rat dorsal root ganglia. Ann Anat 205:9\u201315. https:\/\/doi.org\/10.1016\/j.aanat.2016.01.004","journal-title":"Ann Anat"},{"issue":"7","key":"5108_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1212\/wnl.54.7.1459","volume":"54","author":"T Kanda","year":"2000","unstructured":"Kanda T, Yamawaki M, Iwasaki T, Mizusawa H (2000) Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy. Neurology 54(7):1459\u20131464. https:\/\/doi.org\/10.1212\/wnl.54.7.1459","journal-title":"Neurology"},{"issue":"2","key":"5108_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1468-1331.2006.01161.x","volume":"13","author":"S Mata","year":"2006","unstructured":"Mata S, Galli E, Amantini A, Pinto F, Sorbi S, Lolli F (2006) Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome. Eur J Neurol 13(2):153\u2013160. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01161.x","journal-title":"Eur J Neurol"},{"issue":"7","key":"5108_CR25","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1074\/mcp.M115.056036","volume":"15","author":"RH Ziganshin","year":"2016","unstructured":"Ziganshin RH, Ivanova OM, Lomakin YA, Belogurov AA Jr, Kovalchuk SI, Azarkin IV, Arapidi GP, Anikanov NA, Shender VO, Piradov MA, Suponeva NA, Vorobyeva AA, Gabibov AG, Ivanov VT, Govorun VM (2016) The pathogenesis of the demyelinating form of Guillain-Barre Syndrome (GBS): proteo-peptidomic and immunological profiling of physiological fluids. Mol Cell Proteomics 15(7):2366\u20132378. https:\/\/doi.org\/10.1074\/mcp.M115.056036","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"5108_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40(4):635\u2013644. https:\/\/doi.org\/10.1002\/ana.410400414","journal-title":"Ann Neurol"},{"issue":"5","key":"5108_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39(5):625\u2013635. https:\/\/doi.org\/10.1002\/ana.410390512","journal-title":"Ann Neurol"},{"issue":"9497","key":"5108_CR28","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366(9497):1653\u20131666. https:\/\/doi.org\/10.1016\/S0140-6736(05)67665-9","journal-title":"Lancet"},{"issue":"1-2","key":"5108_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s0165-5728(99)00195-2","volume":"100","author":"RAC Hughes","year":"1999","unstructured":"Hughes RAC, Hadden RDM, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain\u2013Barr\u00e9 syndrome. J Neuroimmunol 100(1-2):74\u201397. https:\/\/doi.org\/10.1016\/s0165-5728(99)00195-2","journal-title":"J Neuroimmunol"},{"issue":"2","key":"5108_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mus.20076","volume":"30","author":"BC Kieseier","year":"2004","unstructured":"Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30(2):131\u2013156. https:\/\/doi.org\/10.1002\/mus.20076","journal-title":"Muscle Nerve"},{"issue":"8","key":"5108_CR31","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/wnl.53.8.1683","volume":"53","author":"A Creange","year":"1999","unstructured":"Creange A, Sharshar T, Planchenault T, Christov C, Poron F, Raphael JC, Gherardi RK (1999) Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome. Neurology 53(8):1683\u20131691. https:\/\/doi.org\/10.1212\/wnl.53.8.1683","journal-title":"Neurology"},{"issue":"3","key":"5108_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000076357","volume":"17","author":"H Schmidt","year":"2004","unstructured":"Schmidt H, Otto M, Niedmann P, Cepek L, Schroter A, Kretzschmar HA, Poser S (2004) CSF lactate dehydrogenase activity in patients with Creutzfeldt-Jakob disease exceeds that in other dementias. Dement Geriatr Cogn Disord 17(3):204\u2013206. https:\/\/doi.org\/10.1159\/000076357","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"5108_CR33","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1111\/jvim.15606","volume":"33","author":"CL Mariani","year":"2019","unstructured":"Mariani CL, Nye CJ, Tokarz DA, Green L, Lau J, Zidan N, Early PJ, Guevar J, Munana KR, Olby NJ, Miles S (2019) Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders. J Vet Intern Med 33(6):2701\u20132708. https:\/\/doi.org\/10.1111\/jvim.15606","journal-title":"J Vet Intern Med"},{"key":"5108_CR34","doi-asserted-by":"publisher","first-page":"105395","DOI":"10.1016\/j.tvjl.2019.105395","volume":"254","author":"M Portero","year":"2019","unstructured":"Portero M, Martinez de Merlo E, Perez C, Benito M, Daza MA, Fragio C (2019) Cerebrospinal fluid and blood lactate concentrations as prognostic biomarkers in dogs with meningoencephalitis of unknown origin. Vet J 254:105395. https:\/\/doi.org\/10.1016\/j.tvjl.2019.105395","journal-title":"Vet J"},{"key":"5108_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00001","volume":"6","author":"CS Palmer","year":"2015","unstructured":"Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM (2015) Glucose metabolism regulates T cell activation, differentiation, and functions. Front Neurol 6:1. https:\/\/doi.org\/10.3389\/fimmu.2015.00001","journal-title":"Front Neurol"},{"key":"5108_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-015-0542-4","volume":"17","author":"Z Yang","year":"2015","unstructured":"Yang Z, Matteson EL, Goronzy JJ, Weyand CM (2015) T cell metabolism in autoimmune disease. Arthritis Res Ther 17:29. https:\/\/doi.org\/10.1186\/s13075-015-0542-4","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5108_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/adc.87.3.255","volume":"87","author":"M Nussinovitch","year":"2002","unstructured":"Nussinovitch M, Prais D, Finkelstein Y, Harel D, Amir J, Volovitz B (2002) Lactic dehydrogenase isoenzymes in cerebrospinal fluid of children with Guillain-Barre syndrome. Arch Dis Child 87(3):255\u2013256. https:\/\/doi.org\/10.1136\/adc.87.3.255","journal-title":"Arch Dis Child"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05108-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T03:38:38Z","timestamp":1631763518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5108"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05108-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of Tianjin Medical University General Hospital and followed the principles outlined in the Declaration of Helsinki for all human experimental investigations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}